ALLIANCEBERNSTEIN L.P. - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 101 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$158,000
-8.7%
35,1000.0%0.00%
Q4 2020$173,000
-16.8%
35,1000.0%0.00%
Q3 2020$208,000
+123.7%
35,1000.0%0.00%
Q2 2020$93,000
+132.5%
35,100
+71.2%
0.00%
Q1 2020$40,000
-72.4%
20,5000.0%0.00%
Q4 2019$145,000
-28.2%
20,5000.0%0.00%
Q3 2019$202,000
+2.0%
20,500
+18.5%
0.00%
Q2 2019$198,00017,3000.00%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 3,661,237$14,901,0000.56%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,553,398$26,672,0000.47%
Alpine Global Management, LLC 354,524$1,443,0000.20%
DELTEC ASSET MANAGEMENT LLC 275,500$1,121,0000.15%
Kamunting Street Capital Management, L.P. 67,594$275,0000.11%
IHT Wealth Management, LLC 340,147$1,384,0000.09%
Redmile Group, LLC 1,358,825$5,530,0000.08%
GSA CAPITAL PARTNERS LLP 173,318$705,0000.08%
ArrowMark Colorado Holdings LLC 1,815,091$7,387,0000.06%
GPS Wealth Strategies Group, LLC 49,025$200,0000.05%
View complete list of XERIS PHARMACEUTICALS INC shareholders